title: V beta 17 T-cell receptor peptide vaccine. Results of a phase I dose-finding study in patients with rheumatoid arthritis.
authors.affiliation: University of Alabama at Birmingham 068 Spain Rehabilitation Center 35294-0006, USA.
authors.forename: L W
authors.initials: LW
authors.lastname: Moreland
authors.forename: L W
authors.initials: LW
authors.lastname: Heck
authors.forename: W J
authors.initials: WJ
authors.lastname: Koopman
authors.forename: P A
authors.initials: PA
authors.lastname: Saway
authors.forename: T C
authors.initials: TC
authors.lastname: Adamson
authors.forename: Z
authors.initials: Z
authors.lastname: Fronek
authors.forename: R D
authors.initials: RD
authors.lastname: O'Connor
authors.forename: E E
authors.initials: EE
authors.lastname: Morgan
authors.forename: J P
authors.initials: JP
authors.lastname: Diveley
authors.forename: N M
authors.initials: NM
authors.lastname: Chieffo
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D004306:Dose-Response Relationship, Immunologic; D015333:Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; D006801:Humans; D007167:Immunotherapy; D008213:Lymphocyte Activation; D010455:Peptides / Q000276:immunology; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000737:chemistry / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D014611:Vaccination
chemical_list: D010455:Peptides; D016693:Receptors, Antigen, T-Cell, alpha-beta